Hartmut Jaeschke reports the receipt of funding by National Institutes of Health grants R01 NIDDK102142 and R01 NIDDK070195
Xie, Y et al Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation BMJ Medicine, March 18, 2026
found that application of barrier creams containing glutathione resulted in a significant reduction in reactivity to chromium and cement extract when compared with the untreated skin.[] SYSTEMIC SCLEROSIS Recently, cellular redox state has been observed to play a significant role in the progression of systemic sclerosis
Cognitive scores, measured by the Mattis DRS-2, depicted a 5-point advantage at 12 months, a 6.3 advantage at 14 months, and a 5.3-point advantage at 24 months of exenatide compared to controls [86]
Melatonin demonstrates effectiveness in mitigating blood-brain barrier (BBB) damage through several mechanisms
To identify gene sets enriched in samples showing synergistic effects compared with samples without synergistic effects, GSEA was performed using javaGSEA desktop application (GSEA v2.1.0) 27,28
